Fulvestrant plus neratinib reversed treatment-acquired HER2 mutations in metastatic ER+ breast cancerMarch 19, 2018Breast Cancer
Gaps exist in receipt of clinically indicated genetic counseling after breast cancer diagnosisMarch 12, 2018Breast Cancer
Measurement of physical activity and sedentary behavior in breast cancer survivorsFebruary 19, 2018Breast Cancer
Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancerFebruary 19, 2018Breast Cancer
PAM50-based score identifies low-risk subset with node-positive early-stage breast cancerFebruary 8, 2018Breast Cancer
